Skip to main content

Advertisement

SpringerLink
Log in

Eustachian Tube Dysfunction, Eosinophilic Otitis Media, Endolymphatic Hydrops, and the Role of Allergic Rhinitis

  • Otolaryngic Allergy (M Platt and C Brook, Section Editors)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To summarize and review current evidence supporting the relationship between allergies and eustachian tube dysfunction (ETD), eosinophilic otitis media (EOM), and endolymphatic hydrops (Meniere’s Disease).

Recent Findings

A unified airway model used to link the middle ear mucosa with nasal mucosa implicates mucosal and inner ear inflammation as a possible mechanism of otologic symptoms in allergy.

Summary

Allergic disease may play a role in ETD, EOM, and endolymphatic hydrops. Continued collaborative efforts are needed to elucidate the local and systemic allergic mechanisms contributing to otologic disease and the medical and surgical approaches available to address each specific condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

(Copyright © 2022 UpToDate, Inc. and its affiliates and/or licensors. All rights reserved.)

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lim D. Functional morphology of the lining membrane of the middle ear and Eustachian tube: an overview. Ann Otol Rhinol Laryngol. 1974;Mar-Apr(83):Suppl 11:5–26.

  2. Kariya S, Okano M, Hattori H, Sugata Y, Matsumoto R, Fukushima K, et al. Th1/Th2 and Regulatory Cytokines in Adults With Otitis Media With Effusion. Otol Neurotol. 2006;27(8):1089–93.

    Article  Google Scholar 

  3. Marple BF. Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace. Am J Rhinol Allergy. 2010;4:249–54.

    Article  Google Scholar 

  4. Hurst DS. Association of otitis media with efision and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear efisions and mucosal biopsies. Laryngoscope. 1996;106(September):1128–37.

    Article  CAS  Google Scholar 

  5. Hurst DS, Venge P. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy. 2000;55(6):435–41.

    Article  CAS  Google Scholar 

  6. •• White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;(379):1060–70. This review article provides a comprehensive overview of AERD and describes in detail the mechanisms that underlie this disorder.

  7. Adappa ND, Ranasinghe VJ, Trope M, Brooks SG, Glicksman JT, Parasher AK, et al. Desensitization in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol. 2018;8(1):49–53.

    Article  Google Scholar 

  8. • Naples JG, Corr A, Tripathi S, Berman M, Brant JA, Ruckenstein MJ, et al. Endoscopic sinus surgery and aspirin desensitization improve otologic-specific SNOT-22 scores. World J Otorhinolaryngol Neck Surg [Internet]. 2020;6(4):248–54. Available from: https://doi.org/10.1016/j.wjorl.2020.07.006. This research demonstrated the otologic symptoms and SNOT-22 otologic subdomains can be improved with sinus surgery and aspirin desensitization.

  9. Mullur J, Singer J, Roditi R, Cahill KN. Hearing loss and middle ear symptoms in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pr. 2019;7(5):1671–2.

    Article  Google Scholar 

  10. Tucci DL, Mccoul ED, Rosenfeld RM, Tunkel DE, Batra PS, Chandrasekhar SS, et al. Clinical consensus statement: balloon dilation of the eustachian tube. Otolaryngol Neck Surg. 2019;161(1):6–17.

    Article  Google Scholar 

  11. Vila PM, Thomas T, Liu C, Poe D, Shin JJ. The burden and epidemiology of eustachian tube dysfunction in adults. Otolaryngol Neck Surg. 2017;156(2):278–84.

    Article  Google Scholar 

  12. Llewellyn A, Norman G, Harden M, Coatesworth A, Kimberling D, Schilder A, et al. Interventions for adult Eustachian tube dysfunction: a systematic review. Heal Technol Assess. 2014;18(46).

  13. Schilder AG, Bhutta MF, Butler CC, Holy C, Levine LH, Kvaerner KJ, et al. Eustachian tube dysfunction: consensus statement on definition, types, clinical presentation and diagnosis. Clin Otolaryngol. 2015;40:407–11.

    Article  CAS  Google Scholar 

  14. Alper CM, Luntz M, Takahashi H, Ghadiali SN, Swarts JD, Teixeira MS. Panel 2: Anatomy ( Eustachian Tube, Middle Ear, and Mastoid — Anatomy, Physiology, Pathophysiology, and Pathogenesis ). Otolaryngol Head Neck Surg. 2017;156(4S):S22-40.

    Article  Google Scholar 

  15. Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(February):108–352.

    PubMed  PubMed Central  Google Scholar 

  16. Alper CM, Teixeira MS, Swarts JD, Doyle WJ. Quantitative description of eustachian tube movements during swallowing as visualized by transnasal videoendoscopy. JAMA Otolaryngol Neck Surg. 2015;141(2):160–8.

    Article  Google Scholar 

  17. Poe DS, Pyykko I. Measurements of eustachian tube dilation by video endoscopy. Otol Neurotol. 2011;32(5):794–8.

    Article  Google Scholar 

  18. Mccoul ED, Anand VK, Christos PJ. Validating the clinical assessment of eustachian tube dysfunction: the Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Laryngoscope. 2012;122(May):1137–41.

    Article  Google Scholar 

  19. Hurst DS, Gordon BR, Mcdaniel AB, Poe DS. Intradermal testing doubles identification of allergy among 110 immunotherapy-responsive patients with eustachian tube dysfunction. diagnostics. 2021;11(763).

  20. Zhu ZH, Shan YJ, Han Y, Zhu LW, Ma ZX. Pathological study of otitis media with effusion after treatment with intranasal pulmonary surfactant. laryngoscope. 2013;123(December):3148–55.

  21. US Food and Drug Administration. FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction. 2016.

  22. Poe D, Anand V, Dean M, Roberts WH, Stolovitzky JP, Hoffmann K, et al. Balloon dilation of the eustachian tube for dilatory dysfunction: a randomized controlled trial. Laryngoscope. 2018;128(May):1200–6.

    Article  Google Scholar 

  23. •• Anand V, Poe D, Dean M, Roberts W, Stolovitzky P, Hoffmann K, et al. Balloon dilation of the eustachian tube: 12-month follow-up of the randomized controlled trial treatment group. Otolaryngol Neck Surg. 2019;160(4):687–94. This was a long-term clinical trial that demonstrated that balloon dilation of the ET normalizes the tympanogram in patients and improves the ET questionnaire scores in patients with obstructive ET dysfunction.

  24. Iino Y, Tomioka-matsutani S, Matsubara A, Nakagawa T. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011;38:456–61.

    Article  Google Scholar 

  25. Seo Y, Nonaka M, Pawankar R. Eosinophilic otitis media and comorbid asthma. Curr Opin Allergy. 2020;20(1):9–13.

    Article  Google Scholar 

  26. Iino Y. Eosinophilic otitis media: a new middle ear disease entity. Curr Allergy Asthma Rep. 2008;8:525–30.

    Article  Google Scholar 

  27. Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol. 2003;123:383–7.

    Article  CAS  Google Scholar 

  28. Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy. 2005;35(1):1370–6.

    Article  CAS  Google Scholar 

  29. Ohta N, Ishida A, Kurakami K, Suzuki Y, Kakehata S, Ono J, et al. Expressions and roles of periostin in otolaryngological diseases. Allergol Int [Internet]. 2014;63(2):171–80. Available from: https://doi.org/10.2332/allergolint.13-RAI-0673.

  30. Lara-Sanchez H, Vallejo BA. Eosinophilic Otitis Media. N Engl J Med. 2017;376(7).

  31. Iwasaki S, Nagura M, Mizuta K. Cochlear implantation in a patient with eosinophilic otitis media. Eur Arch Otorhinolaryngol. 2006;263:365–9.

    Article  Google Scholar 

  32. Kojima H, Sakurai Y, Rikitake M, Tanaka Y. Cochlear implantation in patients with chronic otitis media. Auris Nasus Larynx [Internet]. 2021;37(4):415–21. Available from: https://doi.org/10.1016/j.anl.2010.01.009.

  33. Iino Y, Nagamine H, Kakizaki K, Komiya T. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol [Internet]. 2006;97(6):761–6. Available from: https://doi.org/10.1016/S1081-1206(10)60967-2.

  34. Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, et al. Clinical efficacy of anti-ige therapy for eosinophilic otitis media. Otol Neurotol. 2012;33:1218–24.

    Article  Google Scholar 

  35. Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, et al. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media. Acta Otolaryngol. 2014;134:366–72.

    Article  CAS  Google Scholar 

  36. Seo Y, Nonaka M. Optimal control of asthma improved eosinophilic otitis media. Asia Pac Allergy. 2018;8(1):1–13.

    Article  Google Scholar 

  37. Suzaki I, Kimura Y, Tanaka A, Hirano K. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab. Auris Nasus Larynx [Internet]. 2019;46(1):141–6. Available from: https://doi.org/10.1016/j.anl.2018.05.007.

  38. Iino Y, Takahashi E, Ida S, Kikuchi S. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media. Auris Nasus Larynx [Internet]. 2019;46(2):196–203. Available from: https://doi.org/10.1016/j.anl.2018.07.011.

  39. Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R, et al. Clinical Practice Guideline: Meniere’s Disease. Otolaryngol Neck Surg. 2020;162(2S):S1-55.

    Article  Google Scholar 

  40. Altermatt HJ, Gebbersb J, Müller C, Arnold W, Albert J. Human endolymphatic sac: evidence for a role in inner ear immune defence. ORL. 1990;52:143–8.

    Article  CAS  Google Scholar 

  41. Derebery MJ, Berliner KI. Allergy and its relation to Meniere’s disease. Otolaryngol Clin N Am. 2010;43:1047–58.

    Article  Google Scholar 

  42. Derebery MJ, Angeles L. Allergic management of Meniere’s disease: an outcome study. Otolaryngol Neck Surg. 2000;122(2):174–82.

    Article  CAS  Google Scholar 

  43. Purushotham S, Georgalas C, Papesch M. Co-morbidity of migraine and Ménière’s disease – is allergy the link? J Laryngol Otol. 2005;119(June):455–60.

    Google Scholar 

  44. Mcrackan TR, Best J, Pearce EC, Bennett ML, Dietrich M, Wanna GB, et al. Intratympanic dexamethasone as a symptomatic treatment for Meniere’s disease. Otol Neurotol. 2014;35(5):1638–40.

    Article  Google Scholar 

  45. Boleas-Aguirre MS, Lin FR, Santina CC Della, Minor LB, Carey JP. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière’s disease. Otol Neurotol. 2010;29(1):33–8.

  46. Naples JG, Henry L, Brant JA, Eliades SJ, Ruckenstein MJ. Intratympanic therapies in ménière disease: evaluation of outcomes and early vertigo control. Laryngoscope. 2018;129(Jan):216–21.

  47. Welling DB, Nagaraja HN. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol Neck Surg. 2000;122(340–345).

  48. Thomsen J, Bretlau P, Johnsen N., Hospital G. Meniere’s disease: endolymphatic sac decompression compared with sham (placebo) decompression. Ann New York Acad Sci. 1981;820–30.

  49. Yang B, Brook CD. The Role of Allergy in Otologic Disease. Otolaryngol Clin NA [Internet]. 2017;50(6):1091–101. Available from: https://doi.org/10.1016/j.otc.2017.08.005.

  50. Dziadziola JK, Laurikainen ESAL, Rachel JD, Quirk WS. Betahistine increases vestibular blood flow. Otolaryngol Neck Surg. 1999;120:400–5.

    Article  CAS  Google Scholar 

  51. Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U. Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;(352):h6816.

Download references

Author information

Authors and Affiliations

  1. Division of Otolaryngology-Head and Neck Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis St, Suite 6E, Otology/Neurotology Boston, MA, 02215, USA

    Victoria W. Huang & James Naples

Authors
  1. Victoria W. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Naples
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Naples.

Ethics declarations

Conflict of Interest

Dr. Naples reports he is a paid editor for an online Otolaryngology curriculum published through DeckerMed Publisher ($10,000). Dr. Huang declares no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Otolaryngic Allergy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, V.W., Naples, J. Eustachian Tube Dysfunction, Eosinophilic Otitis Media, Endolymphatic Hydrops, and the Role of Allergic Rhinitis. Curr Otorhinolaryngol Rep 10, 202–207 (2022). https://doi.org/10.1007/s40136-022-00391-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-022-00391-9

Keywords

Search

Navigation